Cardiovascular Journal of Africa: Vol 31 No 3 (May/June 2020)

27 / 64

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 31, No 3, May/June 2020 AFRICA 135
et al. Primary hyperaldosteronism in essential hypertensives: prevalence,
biochemical profile, and molecular biology. J Clin Endocrinol Metab
2000; 85(5): 1863–1867.
8. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al.
Prospective study of the prevalence of primary aldosteronism in 1,125
hypertensive patients. J Am Coll Cardiol 2006; 48(11): 2293–2300.
9. Hannemann A, Wallaschofski H. Prevalence of primary aldosteronism
in patient’s cohorts and in population-based studies – a review of the
current literature. Horm Metab Res 2012; 44(3): 157–162.
10. Malan L, Hamer M, Frasure-Smith N, Steyn HS, Malan NT. COHORT
PROFILE: Sympathetic activity and Ambulatory Blood Pressure in
Africans (SABPA) Prospective Cohort Study. Int J Epidem 2015; 44(6):
1814–1822.
11. Stowasser M, Ahmed A, Guo Z, Wolley M, Ungerer J, McWhinney B,
et al. Can screening and confirmatory testing in the management of
patients with primary aldosteronism be improved? Horm Metab Res
2017 Dec; 49(12): 915–921.
12. The World Medical Association Declaration of Helsinki. Ethical princi-
ples for medical research involving human participants. 2008; Available
at: Accessed 05/21,2009.
13. Obrist PA. Cardiovascular Psychophysiology: A Perspective . New York:
Plenum Press, 1981.
14. Marfell-JonesM, Olds T, Stewart A, Carter L. International Standards for
Anthropometric Assessment. International Society for the Advancement
of Kinanthropometry, 2006: 137.
15. Pilz S, Trummer C, Verheyen N, Schwetz V, Pandis M, Aberer F, et al.
Mineralocorticoid receptor blockers and aldosterone to renin ratio: A
randomized controlled trial and observational data. Horm Metab Res
2018; 50: 375–382.
16. Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H,
et al. The management of primary aldosteronism: Case detection, diag-
nosis, and treatment: An Endocrine Society Clinical Practice Guideline.
J Clin Endocrinol Metab May 2016; 101(5): 1889-1916.
17. Born-Frontsberg E, Reincke M, Rump LC, Hahner S, Diederich S,
Lorenz B, et al. Cardiovascular and cerebrovascular comorbidities of
hypokalemic and normokalemic primary aldosteronism: Results of the
German Conn’s Registry. J Clin Endocrinol Metab April 2009; 94(4):
1125–1130.
18. Pun PH, Goldstein BA, Gallis JA, Middleton JP, Svetkey LP. Serum
potassium levels and risk of sudden cardiac death among patients with
chronic kidney disease and significant coronary artery disease. Kidney
Int Rep 2017; 2(6): 1122–1131.
19. Stehouwer CDA, Henry RMA, Dekker JM, Nijpels G, Heine RJ,
Bouter LM. Microalbuminuria is associated with impaired brachial
artery, flow-mediated vasodilation in elderly individuals without and
with diabetes: Further evidence for a link between microalbuminuria
and endothelial dysfunction – The Hoorn Study. Kidney Intern 2004;
66(92): S42–S44.
20. Syed SB, Qureshi MA. Association of aldosterone and cortisol with
cardiovascular risk factors in prehypertension stage. Int J Hypertens
2012; 2012 : 1–8.
21. De Vos AC, Malan L, Seedat YK, Cockeran M, Malan NT. Chronic
depression symptoms desensitize renin activity to protect against volume
overloading hypertension in blacks: the SABPA study. Phys Behav 2018;
194: 474–480.
22. Malan L, Schutte CE, Alkerwi A, Stranges S, Malan NT. Hypothalamic-
pituitary-adrenal-axis dysregulation and double product increases
potentiate ischemic heart disease risk in a black male cohort: The
SABPA study. Hypertens Res 2017; 40(6): 590–597.
23. Opie LH, Seedat YK. Hypertension in sub-Saharan African popula-
tions. Circulation 2005; 112: 3562–3568.
24. Jones ES, Spence JD, Mcintyre AD, Nondi J, Gogo K, Akintunde A, et
al. High frequency of variants of candidate genes in black Africans with
low renin-resistant hypertension. Am J Hypertens 2017; 30(5): 478–483.
25. Spence JD. Hypertension in Africa. Eur J Prev Cardiol 2019; 26(5):
455–457.
26. Akintunde A, Nondi J, Gogo K, Jones ESW, Rayner BL, Hackam DG,
et al. Physiological phenotyping for personalized therapy of uncon-
trolled hypertension in Africa. Am J Hypertens 2017; 30(9): 923–930.
27. Spence JD, Rayner BL. Hypertension in blacks: Individualized therapy
based on renin/aldosterone phenotyping. Hypertension 2018; 72(2):
263–269.